Tolerance of Anti-Cancer Therapy in the Elderly
NCT05251922 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2022-02-23
Summary
This is a multicentre observational study evaluating frailty and tolerance of chemotherapy in the elderly.
Conditions
- Frailty
- Chemotherapeutic Toxicity
Sponsors & Collaborators
-
The Leeds Teaching Hospitals NHS Trust
lead OTHER
Principal Investigators
-
Helen C Dearden · [email protected]
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-01
- Primary Completion
- 2023-01-01
- Completion
- 2023-06-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Cancer Related Fatigue in Patients Receiving Chemotherapy
NCT00261534 ·Status: UNKNOWN
-
Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer
NCT00059943 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan in Treating Aging Patients With Solid Tumors
NCT00026195 ·Status: COMPLETED ·Phase: PHASE1
-
Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment
NCT06383325 ·Status: NOT_YET_RECRUITING
-
Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity
NCT03553654 ·Status: COMPLETED ·Phase: NA
-
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
NCT04042298 ·Status: COMPLETED
-
Optimization of the Targeted Anticancer Therapies
NCT04484064 ·Status: RECRUITING ·Phase: NA
-
Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
NCT00382733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring
NCT01053104 ·Status: COMPLETED
-
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
NCT04663100 ·Status: RECRUITING ·Phase: NA
-
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
NCT03987555 ·Status: SUSPENDED
-
Optimizing the Management of Patients With Oral Therapy
NCT03623490 ·Status: TERMINATED ·Phase: NA
-
Preparatory Work to Assess Adherence to Oral Chemotherapy
NCT02895542 ·Status: COMPLETED
-
Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer
NCT00002537 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
NCT06274268 ·Status: RECRUITING ·Phase: NA
-
A Phase I, Open-label Study to Assess Bioavailability of a Single Oral Dose of AZD9291 vs an IV Dose of [14C]AZD9291
NCT02491944 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Occupational Exposure to Antineoplastic Drugs
NCT06343103 ·Status: RECRUITING ·Phase: NA
-
Observational Study to Assess Adherence Oral Anticancer Therapies
NCT03195972 ·Status: COMPLETED
-
Onco-haematology Vigilance Card
NCT04931329 ·Status: UNKNOWN
-
Pilot Study of a Pharmacy Intervention for Older Adults With Cancer
NCT02871115 ·Status: COMPLETED ·Phase: NA
-
Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer
NCT01125995 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
NCT04733534 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Late Anthracycline Induced Cardiotoxicity- Childhood Cancer Survivors
NCT04852965 ·Status: ACTIVE_NOT_RECRUITING
-
Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients
NCT00851448 ·Status: TERMINATED ·Phase: NA
-
Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study
NCT04260269 ·Status: ENROLLING_BY_INVITATION